Drug name - Cambia

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8097651 ASSERTIO Diclofenac formulations and methods of use
Jun, 2026

(3 years from now)

US7759394 ASSERTIO Diclofenac formulations and methods of use
Jun, 2026

(3 years from now)

CN101272768A ASSERTIO Diclofenac Formulations And Methods Of Use
Nov, 2015

(6 years ago)

EP2705837A1 ASSERTIO Diclofenac Formulation
Jun, 2026

(3 years from now)

EP2705837B1 ASSERTIO Diclofenac Formulation
Jun, 2026

(3 years from now)

EP1890680A2 ASSERTIO Diclofenac Formulations And Methods Of Use
Jun, 2026

(3 years from now)

EP2402003B1 ASSERTIO Diclofenac Formulations And Methods Of Use
Jun, 2026

(3 years from now)

EP3103441A1 ASSERTIO Diclofenac Formulations And Methods Of Use
Jun, 2026

(3 years from now)

EP2402003A2 ASSERTIO Diclofenac Formulations And Methods Of Use
Jun, 2026

(3 years from now)

EP3103441B1 ASSERTIO Diclofenac Formulations And Methods Of Use
Jun, 2026

(3 years from now)

EP1890680B1 ASSERTIO Diclofenac Formulations And Methods Of Use
Jun, 2026

(3 years from now)

EP2402003A3 ASSERTIO Diclofenac Formulations And Methods Of Use
Jun, 2026

(3 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8927604 ASSERTIO Diclofenac formulations and methods of use Jun, 2026

(3 years from now)

US9827197 ASSERTIO Diclofenac formulations and methods of use Jun, 2026

(3 years from now)

Drugs and Companies using DICLOFENAC POTASSIUM ingredient

Treatment: Acute treatment of migraine attacks with or without aura in adults

Dosage: FOR SOLUTION;ORAL

More Information on Dosage
Strength Dosage Availability
50MG FOR SOLUTION;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.